• About
  • Privacy Policy
  • Cookie Policy
  • Terms of Use 
  • My account
  • Contact
Wednesday, May 14, 2025
  • Login
Arab Health World
Advertisement
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
Arab Health World
No Result
View All Result
  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact
Home Digital Pathology

World Cancer Day: Half of Cancer Deaths Can Be Prevented

admin by admin
February 4, 2023
in Digital Pathology
0
0
World Cancer Day: Half of Cancer Deaths Can Be Prevented
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Patricia McKnight

Nearly half of all deaths from cancer are caused by known modifiable risk factors, with smoking, alcohol consumption, and high body mass index (BMI) among the top three, notes the Union for International Cancer Control (UICC).

Contributing to the high BMI are products such as sugary drinks and ultra-processed foods, which the group maintains are — like tobacco and alcohol — potentially addictive.

For World Cancer Day today, February 4, the group is calling on governments across the globe to help prevent millions of avoidable cancer-related deaths by implementing policies targeting big companies that advertise alcohol and tobacco products, and ultra-processed foods.

All these products are marketed by companies whose corporate interests often outweigh concerns for global health, the group comments.

The UICC believes the companies promoting these products and unhealthy lifestyle choices should be held responsible and have hefty restrictions on marketing and selling. 

“Millions of avoidable cancer deaths are caused by unhealthy products sold by heartless companies who interfere in policy debates and misuse science to secure a favorable commercial environment,” Cary Adams, the UICC’s CEO, lamented. “As we celebrate World Cancer Day, UICC stands ready to support governments in their efforts to limit people’s exposure to tobacco, alcohol, and ultra-processed food products.”

The UICC recommends a four-pronged approach to reduce the availability and consumption of unhealthy products that are linked to cancer-related deaths. 

First, UICC recommends increasing taxation on tobacco and alcohol but also sugar-sweetened beverages like soda, juice, and energy and sports drinks. These sugary drinks are known drivers of obesity which in turn contribute to high BMI, a modifiable cancer risk factor. 

The idea behind taxation on sugar drinks, referred to as sugar tax or soda tax, is that such a tax would help reduce the consumption of sugar akin to taxing cigarettes to reduce tobacco use. 

“Many governments know that their populations are targeted by companies eager to sell unhealthy products but their ambitions to curtail these actions are often met with resistance from industry actors, including legal challenges to effective policy measures and legislation,” said Ulrike Årehed Kågström, president-elect of UICC and secretary general of the Swedish Cancer Society. “Opposition to a sugar tax by manufacturers of sugary drinks, stealing a page out of Big Tobacco’s playbook, is just one example among many.”

The second recommendation is to increase marketing limitations including age restrictions and reduced points of sale. The UICC referenced a United Kingdom government analysis that analyzed the impact of junk food advertisements on television before 9 PM. The analysis suggested that banning the ads would result in £1.9 billion ($2.3 billion US) in public health benefits with reductions in obesity-related ill health over children’s lifetimes.

The third policy recommendation is to enhance labeling which would impose warning and information labels. At present, only tobacco products carry health warnings. Efforts  to introduce labeling about increased cancer risk on alcoholic beverages have been met with fierce opposition from the alcohol industry, as previously reported by Medscape Medical News.

The fourth suggestion is to run extensive public education campaigns to improve knowledge of risk factors, and further counter misleading advertising, market promotion, and policy interference.

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
admin

admin

Related Posts

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
Artificial Intellegance

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

by admin
April 30, 2025
0

No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip...

Read moreDetails

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Sidra Medicine Launches Campaign Highlighting Commitment to Women’s and Children’s Health and Vision 2030

Treatment in Oman pavilion, under the Directorate General of Private Health Institutions, showcases Omani hospitals and medical institutions that rival international standards. Book your free visit now and experience excellence in healthcare!

Megatrends shaping healthcare in 2024

MEDICA 2024 + COMPAMED 2024: Know-how and innovations for the healthcare business – international and diverse with more than 6,000 exhibitors

Global Health Exhibition 2024

Practicing visual accessibility in optometry offices

UAE’s vision for longevity in focus at Arab Health’s Future Health Summit

Stay Connected

  • 23.9k Followers
  • Trending
  • Comments
  • Latest
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

September 15, 2024
GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

February 6, 2024
Neonatal resuscitation: A guide to the latest equipment

Neonatal resuscitation: A guide to the latest equipment

July 16, 2024
“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

October 26, 2023

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

0
FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

0
World Cancer Day: Half of Cancer Deaths Can Be Prevented

World Cancer Day: Half of Cancer Deaths Can Be Prevented

0
Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

0
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025

Follow Us

  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact

© 2023 - ArabHealthWorld all rights reserved

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit

© 2023 - ArabHealthWorld all rights reserved